We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPSC icon
2526
Century Therapeutics
IPSC
$353M
-4,939
Closed -$124K
TBHC
2527
DELISTED
The Brand House Collective
TBHC
-5,189
Closed -$99.7K
KODK icon
2528
Kodak
KODK
$992M
-5,624
Closed -$38.3K
LYEL icon
2529
Lyell Immunopharma
LYEL
$347M
-516
Closed -$153K
RJET
2530
Republic Airways Holdings
RJET
$962M
-834
Closed -$95.9K
MLCO icon
2531
Melco Resorts & Entertainment
MLCO
$2.14B
-13,000
Closed -$133K
MTRX icon
2532
Matrix Service
MTRX
$330M
-9,458
Closed -$98.9K
NGNE icon
2533
Neurogene
NGNE
$738M
-218
Closed -$31.6K
NKTR icon
2534
Nektar Therapeutics
NKTR
$2.57B
-5,887
Closed -$1.59M
NKTX icon
2535
Nkarta
NKTX
$171M
-7,243
Closed -$201K
OLO
2536
DELISTED
Olo Inc
OLO
-41,946
Closed -$1.26M
OPEN icon
2537
Opendoor
OPEN
$3.39B
-28,324
Closed -$563K
PATH icon
2538
UiPath
PATH
$7.91B
-88,750
Closed -$4.67M
PAVM icon
2539
PAVmed
PAVM
$30.1M
-40
Closed -$152K
PLSE icon
2540
Pulse Biosciences
PLSE
$3.09B
-5,276
Closed -$114K
PRLD icon
2541
Prelude Therapeutics
PRLD
$456M
-4,148
Closed -$130K
PSTL
2542
Postal Realty Trust
PSTL
$702M
-4,518
Closed -$84.2K
REKR icon
2543
Rekor Systems
REKR
$94M
-11,364
Closed -$131K
RFL icon
2544
Rafael Holdings
RFL
$103M
-4,185
Closed -$127K
SB icon
2545
Safe Bulkers
SB
$760M
-22,514
Closed -$116K
SCOR icon
2546
Comscore
SCOR
$108M
-1,265
Closed -$98.7K
SGHT icon
2547
Sight Sciences
SGHT
$456M
-4,737
Closed -$108K
SKYT
2548
DELISTED
SkyWater Technology
SKYT
-3,580
Closed -$97.4K
SPRY icon
2549
ARS Pharmaceuticals
SPRY
$601M
-9,098
Closed -$90.8K
STTK icon
2550
Shattuck Labs
STTK
$752M
-10,943
Closed -$223K

Similar funds

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.